Stock Price
3.52
Daily Change
-2.03 -36.55%
Monthly
-37.01%
Yearly
-35.74%
Q1 Forecast
5.37

MannKind reported $1.83M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
Insmed USD 765K 55K Sep/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
MannKind USD 1.83M 124K Jun/2025
Merck USD 96M 27M Sep/2025
Novavax USD 303K 27K Dec/2021
Novo Nordisk DKK 3.42B 2.04B Mar/2025
Pfizer USD 0.62 156M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Xencor USD 7.25M 290K Jun/2025